Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice

Diabetes

Volumn 48, Issue 9, 1999, Pages 1830-1835

  Tang, Yan ^a   Osawa, Haruhiko ^a   Onuma, Hiroshi ^a   Nishimiya, Tatsuya ^a   Ochi, Masa Aki ^a   Makino, Hideichi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; MESSENGER RNA; PHOSPHODIESTERASE; PIOGLITAZONE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; OBESITY; THIAZOLES; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 0032847984     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.9.1830     Document Type: Article

References (46)

1. Beavo JA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748, 1995
2. Manganiello VC, Murata T, Taira M, Beifrage P, Degerman E: Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch Biochem Biophys 322:1-13, 1995
3. Degerman E, Belfrage P, Manganiello VC: Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 272:6823-6826, 1997
4. Makino H, Manganiello VC, Kono T Roles of ATP in insulin actions. Annu Rev Physiol 56:273-295, 1994
5. Reinhardt RR, Chin E, Zhou J, Taira M, Murata T, Manganiello VC, Bondy CA: Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases. J Clin Invest 95:1528-1538, 1995 (Erratum published in J Clin Invest 99:551, 1997.)
6. Soderling SH, Bayuga SJ, Beavo JA: Cloning and characterization of a cAMP-speciflc cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci USA 95: 8991-8996, 1998
7. Soderling SH, Bayuga SJ, Beavo JA: Identification and characterization of a novel family of cyclic nucleotide phosphodiesterase. J Biol Chem 273: 15553-15558, 1998
8. Carey GB: Mechanisms regulating adipocyte lipolysis. Adv Exp Med Biol 441:157-170, 1998
9. Large V, Arner P, Reynisdottir S, Grober J, Van Harmelen V, Holm C, Langin D: Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells. J Lipid Res 39:1688-1695, 1998
10. Moberg E, Enoksson S, Hagstrom-Toft E: Importance of phosphodiesterase 3 for the lipolytic response in adipose tissue during insulin-induced hypoglycemia in normal man. Horm Metab Res 30:684-688, 1998
11. Makino H, Suzuki T, Kajinuma H, Yamazaki M, Ito H, Yoshida S: The role of insulin-sensitive phosphodiesterase in insulin action. Ad Second Messenger Phosphoprotein Res 25:185-189, 1992
12. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
13. Bergman RN, Watanabe R, Rebrin K, Ader M, Steil G: Toward an integrated phenotype in pre-NIDDM. Diabet Med 13:S67-S77, 1996
14. Bergman EN: New concepts in extracellular signaling for insulin action: the single gateway hypothesis. Recent Prog Horm Res 52:359-385, 1997
15. Rebrin K, Steil GM, Mittelman SD, Bergman RN: Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749, 1996
16. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
17. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10,1997 (Erratum published in Diabetes 46:536, 1997.)
18. Boden G: Free fatty acids (FFA): a link between obesity and insulin resistance. Front Biosci 3:D169-D175, 1998
19. Makino H, Kanatsuka A, Suzuki T, Kuribayashi S, Hashimoto N, Yoshida S, Nishimura M: Insulin resistance of fat cells from spontaneously diabetic KK mice: analysis of insulin-sensitive phosphodiesterase. Diabetes 34:844-849, 1985
20. Suzuki T, Makino H, Kanatsuka A, Kuribayashi S, Hashimoto N, Yoshida S: Insulin-sensitive phosphodiesterase and insulin receptor binding in fat cells from spontaneously obese rats. Diabetologia 28:286-290, 1985
21. Osegawa M, Makino H, Kanatsuka A, Suzuki T, Yoshida S: Effects of changes in serum insulin in response to dexamethasone and adrenalectomy on insulin-sensitive phosphodiesterase in rat fat cells. Metabolism 33:754-759, 1984
22. Engfeldt P, Amer P, Bolinder J, Ostman J: Phosphodiesterase activity in human subcutaneous adipose tissue in insulin-and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 55:983-988, 1982
23. Solomon SS: Effect of insulin and lipolytic hormones on cyclic AMP phosphodiesterase activity in normal and diabetic rat adipose tissue. Endocrinology 96:1366-1373, 1975
24. Solomon SS, Deaton J, Shankar TP, Palazzolo M: Cyclic AMP phosphodiesterase in diabetes: effect of glyburide. Diabetes 35:1233-1236, 1986
25. Chang AY, Wyse BM, Copeland EJ, Peterson T, Ledbetter SR: The Upjohn colony of KKAy mice: a model for obese type II diabetes. In Diabetes 1985. Serrano-Rios M, Lefebvre PJ, Eds. Elsevier, Amsterdam, 1986, p. 466-470
26. Bonini JA, Colca JR, Dailey C, White M, Hofmann C: Compensatory alterations for insulin signal transduction and glucose transport in insulin-resistant diabetes. Am J Physiol 269:E759-E765, 1995
27. Rodbell M: Metabolism of isolated fat cells. J Biol Chem 239:375-380, 1964
28. Nagaoka T, Shirakawa T, Balon TW, Russell JC, Fujita-Yamaguchi Y: Cyclic nucleotide phosphodiesterase 3 expression in vivo: evidence for tissue-specific expression of phosphodiesterase 3A or 3B mRNA and activity in the aorta and adipose tissue of atherosclerosis-prone insulin-resistant rats. Diabetes 47:1135-1144, 1998
29. Digby JE, Montague CT, Sewter CP, Sanders L, Wilkison WO, O'Rahilly S, Prins JB: Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Diabetes 47:138-141, 1998
30. Szalkowski D, White-Carrington S, Berger J, Zhang B: Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136:1474-1481, 1995
31. Lobbert RW, Winterpacht A, Seipel B, Zabel BU: Molecular cloning and chromosomal assignment of the human homologue of the rat cGMP-inhibited phosphodiesterase 1 (PDE3A): a gene involved in fat metabolism located at 11p 15.1. Genomics 37:211-218, 1996
32. Makino H, de Buschiazzo PM, Pointer RH, Jordan JE, Kono T: Characterization of insulin-sensitive phosphodiesterase in fat cells. I. Effects of salts and oxidation-reduction agents. J Biol Chem 255:7845-7849, 1980
33. Onuma H, Makino H, Osawa H, Suzuki Y, Taira M, Kanatsuka A, Saito Y: Mitogen-activated protein kinase and p70 ribosomal protein S6 kinase are not involved in the insulin-dependent stimulation of cAMP phosphodiesterase kinase in rat adipocytes. Biochim Biophys Acta 1402:197-208, 1998
34. Crandall DL, Goldstein BM, Huggins F, Cervoni P: Adipocyte blood flow: influence of age, anatomic location, and dietary manipulation. Am J Physiol 247:R46-R51, 1984
35. Amer P, Ostman J: Relationship between the tissue level of cyclic AMP and the fat cell size of human adipose tissue. J Lipid Res 19:613-618, 1978
36. Reynisdottir S, Dauzats M, Thorne A, Langin D: Comparison of hormonesensitive lipase activity in visceral and subcutaneous human adipose tissue. J Clin Endocrinol Metab 82:4162-4166, 1997
37. Robinson C, Tamborlane WV, Maggs DG, Enoksson S, Sherwin RS, Silver D, Shulman GI, Caprio S: Effect of insulin on glycerol production in obese adolescents. Am J Physiol 274:E737-E743, 1998
38. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H: Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37:1549-1558, 1988
39. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259, 1999
40. Terasaki J, Anai M, Funaki M, Shibata T, Inukai K, Ogihara T, Ishihara H, Katagiri H, Onishi Y, Sakoda H, Fukushima Y, Yazaki Y, Kikuchi M, Oka Y, Asano T: Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet. Diabetologia 41: 400-409, 1998
41. Wykander J, Landstrom TR, Manganiello V, Belfrage P, Degerman E: Insulininduced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase. Endocrinology 139:219-227, 1998
42. Hayakawa T, Shiraki T, Morimoto T, Shii K, Ikeda H: Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats. Biochem Biophys Res Commun 223:439-444, 1996 (Erratum published in Biochem Biophys Res Commun 236:833, 1997.)
43. Spiegelman BM: PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514, 1998
44. Hallakou S, Doare L, Foufelle F, Kergoat M, Guerre-Millo M, Berthault MF, Dugail I, Morin J, Auwerx J, Ferre P: Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 46:1393-1399, 1997
45. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T: Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101:1354-1361, 1998
46. Taira M, Hockman SC, Calvo JC, Belfrage P, Manganiello VC: Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J Biol Chem 268:18573-18579, 1993